Figure 6.

Increased percentage of CD11b^low/CADO48A^low in tumor-bearing canine patients. The expression levels of CD11b^low and CADO48A^low was evaluated from the peripheral blood of representative canine patients and show an increase of CD11b^low/CADO48^low in tumor-bearing canine patients.